Global Vaccine promises $5 million to develop Ebola vaccine

LONDON – The global vaccine alliance GAVI says it will donate $5 million toward developing the leading Ebola vaccine, hoping that it will be approved by a regulator by the end of 2017.

If the vaccine is given the green light, GAVI says it will then create a stockpile to help stamp out future outbreaks of the lethal disease. The vaccine’s producer, Merck & Co. Inc., says it will ensure that 300,000 doses are available from May for use in advanced trials and emergency use.

In a statement on Wednesday, GAVI CEO Dr. Seth Berkley said “the world is still worryingly underprepared for potential future health threats.”

In 2014 — during the biggest-ever outbreak of Ebola — GAVI pledged to spend $300 million to buy Ebola vaccines for poor countries.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.